TransMedics Maintained at Buy as CHOPS Platform Broadens Transplant Offering; $152 Price Target Reiterated
at www.tipranks.com (Tue, 28-Apr 8:35 AM)
TransMedics Sets Date for Q1 2026 Results—Will Earnings Spark Fresh Momentum?
Market Chameleon (Wed, 22-Apr 7:34 AM)
TransMedics Secures Unconditional FDA IDE Approval for Historic OCS Heart ENHANCE Trial—Will This Redefine Heart Transplant Standards?
Market Chameleon (Mon, 9-Feb 9:02 AM)
